Brazilian Health Authorities widened the age range of potential recipients of the dengue vaccine as many doses were ...

The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.

The Pan American Health Organization (PAHO) has issued an epidemiological alert regarding the increased risk of dengue ...

The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ...

Business debate on research and innovation (R&I) funding in the EU’s new mandate, global health leaders underlined the ...

The state government has extended free Kyasanur Forest Disease (KFD) treatment to all patients, including families above the ...

If AV-1 shows promising results in this clinical trial, researchers may pursue further clinical evaluations of its safety and ...

Deadly viruses could become endemic in Europe unless urgent measures are taken, a leading expert has warned. Rising global ...

First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger ...

The General Directorate of Epidemiology reported low incidences of dengue, cholera, and leptospirosis, as can be seen in ...

Three species of mosquito are of particular concern in Europe, according to the European Centre for Disease Prevention and ...